Association between Alzheimer's disease and the NOS3 gene

M Dahiyat, A Cumming, C Harrington, C Wischik, J Xuereb, F Corrigan, G Breen, D Shaw, D St Clair

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is the most common form of neurodegenerative disorder of later life. Genetic studies have demonstrated that the apolipoprotein E (ApoE) gene is an important susceptibility locus; however, other environmental and genetic factors operating alone or in combination with ApoE must also be involved. Among candidate genes that may contribute to this residual risk is the endothelial nitric oxide synthase (NOS3) gene. NO release from vascular endothelium accounts in large pan for endothelium-derived relaxing factor bioactivity. Abnormalities of cerebral small vessels occur early in AD, and it has been demonstrated recently that beta-amyloid interacts with endothelial cells in blood vessels to produce an excess of superoxide radicals. We have genotyped 122 cases of early-onset AD (EOAD) and 317 cases of late-onset AD (LOAD) as well as 392 controls for a common structural polymorphism Glu/Asp at codon 298 in the NOS3 gene. We find a highly significant enrichment for Glu/Glu homozygotes in LOAD compared with controls. The effect appears to be independent of ApoE status. NOS3 may be a new genetic risk factor for LOAD.

Original languageEnglish
Pages (from-to)664-667
Number of pages4
JournalAnnals of Neurology
Volume46
Publication statusPublished - 1999

Keywords

  • NITRIC-OXIDE SYNTHASE
  • APOLIPOPROTEIN-E
  • ALLELE
  • CELLS

Cite this

Dahiyat, M., Cumming, A., Harrington, C., Wischik, C., Xuereb, J., Corrigan, F., ... St Clair, D. (1999). Association between Alzheimer's disease and the NOS3 gene. Annals of Neurology, 46, 664-667.

Association between Alzheimer's disease and the NOS3 gene. / Dahiyat, M ; Cumming, A ; Harrington, C ; Wischik, C ; Xuereb, J ; Corrigan, F ; Breen, G ; Shaw, D ; St Clair, D .

In: Annals of Neurology, Vol. 46, 1999, p. 664-667.

Research output: Contribution to journalArticle

Dahiyat, M, Cumming, A, Harrington, C, Wischik, C, Xuereb, J, Corrigan, F, Breen, G, Shaw, D & St Clair, D 1999, 'Association between Alzheimer's disease and the NOS3 gene', Annals of Neurology, vol. 46, pp. 664-667.
Dahiyat M, Cumming A, Harrington C, Wischik C, Xuereb J, Corrigan F et al. Association between Alzheimer's disease and the NOS3 gene. Annals of Neurology. 1999;46:664-667.
Dahiyat, M ; Cumming, A ; Harrington, C ; Wischik, C ; Xuereb, J ; Corrigan, F ; Breen, G ; Shaw, D ; St Clair, D . / Association between Alzheimer's disease and the NOS3 gene. In: Annals of Neurology. 1999 ; Vol. 46. pp. 664-667.
@article{3fe179d678e5483ea9ea0eda3642438b,
title = "Association between Alzheimer's disease and the NOS3 gene",
abstract = "Alzheimer's disease (AD) is the most common form of neurodegenerative disorder of later life. Genetic studies have demonstrated that the apolipoprotein E (ApoE) gene is an important susceptibility locus; however, other environmental and genetic factors operating alone or in combination with ApoE must also be involved. Among candidate genes that may contribute to this residual risk is the endothelial nitric oxide synthase (NOS3) gene. NO release from vascular endothelium accounts in large pan for endothelium-derived relaxing factor bioactivity. Abnormalities of cerebral small vessels occur early in AD, and it has been demonstrated recently that beta-amyloid interacts with endothelial cells in blood vessels to produce an excess of superoxide radicals. We have genotyped 122 cases of early-onset AD (EOAD) and 317 cases of late-onset AD (LOAD) as well as 392 controls for a common structural polymorphism Glu/Asp at codon 298 in the NOS3 gene. We find a highly significant enrichment for Glu/Glu homozygotes in LOAD compared with controls. The effect appears to be independent of ApoE status. NOS3 may be a new genetic risk factor for LOAD.",
keywords = "NITRIC-OXIDE SYNTHASE, APOLIPOPROTEIN-E, ALLELE, CELLS",
author = "M Dahiyat and A Cumming and C Harrington and C Wischik and J Xuereb and F Corrigan and G Breen and D Shaw and {St Clair}, D",
year = "1999",
language = "English",
volume = "46",
pages = "664--667",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Association between Alzheimer's disease and the NOS3 gene

AU - Dahiyat, M

AU - Cumming, A

AU - Harrington, C

AU - Wischik, C

AU - Xuereb, J

AU - Corrigan, F

AU - Breen, G

AU - Shaw, D

AU - St Clair, D

PY - 1999

Y1 - 1999

N2 - Alzheimer's disease (AD) is the most common form of neurodegenerative disorder of later life. Genetic studies have demonstrated that the apolipoprotein E (ApoE) gene is an important susceptibility locus; however, other environmental and genetic factors operating alone or in combination with ApoE must also be involved. Among candidate genes that may contribute to this residual risk is the endothelial nitric oxide synthase (NOS3) gene. NO release from vascular endothelium accounts in large pan for endothelium-derived relaxing factor bioactivity. Abnormalities of cerebral small vessels occur early in AD, and it has been demonstrated recently that beta-amyloid interacts with endothelial cells in blood vessels to produce an excess of superoxide radicals. We have genotyped 122 cases of early-onset AD (EOAD) and 317 cases of late-onset AD (LOAD) as well as 392 controls for a common structural polymorphism Glu/Asp at codon 298 in the NOS3 gene. We find a highly significant enrichment for Glu/Glu homozygotes in LOAD compared with controls. The effect appears to be independent of ApoE status. NOS3 may be a new genetic risk factor for LOAD.

AB - Alzheimer's disease (AD) is the most common form of neurodegenerative disorder of later life. Genetic studies have demonstrated that the apolipoprotein E (ApoE) gene is an important susceptibility locus; however, other environmental and genetic factors operating alone or in combination with ApoE must also be involved. Among candidate genes that may contribute to this residual risk is the endothelial nitric oxide synthase (NOS3) gene. NO release from vascular endothelium accounts in large pan for endothelium-derived relaxing factor bioactivity. Abnormalities of cerebral small vessels occur early in AD, and it has been demonstrated recently that beta-amyloid interacts with endothelial cells in blood vessels to produce an excess of superoxide radicals. We have genotyped 122 cases of early-onset AD (EOAD) and 317 cases of late-onset AD (LOAD) as well as 392 controls for a common structural polymorphism Glu/Asp at codon 298 in the NOS3 gene. We find a highly significant enrichment for Glu/Glu homozygotes in LOAD compared with controls. The effect appears to be independent of ApoE status. NOS3 may be a new genetic risk factor for LOAD.

KW - NITRIC-OXIDE SYNTHASE

KW - APOLIPOPROTEIN-E

KW - ALLELE

KW - CELLS

M3 - Article

VL - 46

SP - 664

EP - 667

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

ER -